<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" lang="en">
<head>
<meta http-equiv="default-style" content="application/xhtml+xml; charset=utf-8"/>
<title>Brunner &#38; Suddarth&#8217;s Textbook of Medical-Surgical Nursing, 15e</title>
<link rel="stylesheet" type="text/css" href="style.css"/>
</head>
<body epub:type="bodymatter">
<section epub:type="chapter" title="Cell Structure and Function">
<div id="main_container">
<header>
<h1 id="ch1" class="chapter_name"><span class="chapter_name">Appendix A</span></h1>
<h2 class="chapter_title">Diagnostic Studies and Interpretation</h2>
</header>
<h4 class="h4">Test Value Studied</h4>
<p class="UL1Middle">Reference Ranges&#x2014;Hematology</p>
<p class="UL1Middle">Reference Ranges&#x2014;Serum, Plasma, and Whole Blood Chemistries</p>
<p class="UL1Middle">Reference Ranges&#x2014;Immunodiagnostic Tests</p>
<p class="UL1Middle">Reference Ranges&#x2014;Urine Chemistry</p>
<p class="UL1Middle">Reference Ranges&#x2014;Cerebrospinal Fluid (CSF)</p>
<h4 class="h4">Selected Abbreviations Used in Reference Ranges</h4>
<h5 class="h5">Conventional Units</h5>
<p class="UL1Middle">kg = kilogram</p>
<p class="UL1Middle">gm = gram</p>
<p class="UL1Middle">mg = milligram</p>
<p class="UL1Middle">&#x03BC;g = microgram</p>
<p class="UL1Middle">&#x03BC;&#x03BC;g = micromicrogram</p>
<p class="UL1Middle">ng = nanogram</p>
<p class="UL1Middle">pg = picogram</p>
<p class="UL1Middle">dL = 100 milliliters</p>
<p class="UL1Middle">mL = milliliter</p>
<p class="UL1Middle">mm<sup>3</sup> = cubic millimeter</p>
<p class="UL1Middle">fL = femtoliter</p>
<p class="UL1Middle">mM = millimole</p>
<p class="UL1Middle">nM = nanomole</p>
<p class="UL1Middle">mOsm = milliosmole</p>
<p class="UL1Middle">mm = millimeter</p>
<p class="UL1Middle">&#x03BC;m = micron or micrometer</p>
<p class="UL1Middle">mm Hg = millimeters of mercury</p>
<p class="UL1Middle">U = unit</p>
<p class="UL1Middle">mU = milliunit</p>
<p class="UL1Middle">&#x03BC;U = microunit</p>
<p class="UL1Middle">mEq = milliequivalent</p>
<p class="UL1Middle">IU = international unit</p>
<p class="UL1Middle">mIU = milli-international unit</p>
<h5 class="h5">SI Units</h5>
<p class="indent">g = gram</p>
<p class="indent">L = liter</p>
<p class="indent">d = day</p>
<p class="indent">h = hour</p>
<p class="indent">mol = mole</p>
<p class="indent">mmol = millimole</p>
<p class="indent">&#x03BC;mol = micromole</p>
<p class="indent">nmol = nanomole</p>
<p class="indent">pmol = picomole</p>
<div class="table">
<table class="tbo" id="ttapp1">
<colgroup>
<col style="width:20%"></col>
<col style="width:80%"></col>
</colgroup>
<tr>
<td class="tdnum"><p class="tnum"><strong>TABLE&#x00A0;A-1</strong></p></td>
<td><p class="tcaption">Reference Ranges&#x2014;Hematology<em><sup><a id="fn1" href="#ft1">a</a></sup></em></p></td>
</tr>
</table>
<table class="table">
<tr>
<td class="thead"></td>
<td class="thead_line" colspan="2"><p class="T2-c">Reference Range</p></td>
<td class="thead"></td>
</tr>
<tr>
<td class="thead"><p class="T2">Test</p></td>
<td class="thead"><p class="T2">Conventional Units</p></td>
<td class="thead"><p class="T2">SI Units</p></td>
<td class="thead"><p class="T2">Clinical Significance</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Bleeding time</p></td>
<td class="td1_line"><p class="tbodyleft">3&#x2013;10 min</p><p class="tbodyleft">Ivy method</p></td>
<td class="td1_line"><p class="tbodyleft">3&#x2013;10 min</p></td>
<td class="td1_line"><p class="tbodyleft">Prolonged in thrombocytopenia, defective platelet function, and aspirin therapy</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Factor V assay (labile factor)</p></td>
<td class="td2_line"><p class="tbodyleft">50&#x2013;150%</p></td>
<td class="td2_line"></td>
<td class="td2_line"><p class="tbodyleft">Decreased in liver disease, factor V inhibitors, myeloproliferative disorders, DIC, and fibrinolysis</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Factor VIII assay (&#x00AD;antihemophilic factor)</p></td>
<td class="td1_line"><p class="tbodyleft">55&#x2013;145%</p></td>
<td class="td1_line"><p class="tbodyleft">55&#x2013;145 AU</p></td>
<td class="td1_line"><p class="tbodyleft">Increased in late normal pregnancy, thromboembolic &#x00AD;conditions, liver disease, postoperative period, and rebound period after sudden cessation of a Coumadin-type drug</p>
<p class="tbodyleft">Decreased in hemophilia A, immunologic reactions, &#x00AD;postpartum, von Willebrand disease, DIC, fibrinolysis, and myeloproliferative disorders</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Factor IX assay (&#x00AD;Christmas factor)</p></td>
<td class="td2_line"><p class="tbodyleft">60&#x2013;140%</p></td>
<td class="td2_line"><p class="tbodyleft">60&#x2013;140 AU</p></td>
<td class="td2_line"><p class="tbodyleft">Decreased in uncompensated cirrhosis, liver disease, nephrotic syndrome, various anticoagulant drugs, DIC, and vitamin K deficiency</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Factor X</p></td>
<td class="td1_line"><p class="tbodyleft">45&#x2013;155%</p></td>
<td class="td1_line"></td>
<td class="td1_line"><p class="tbodyleft">Decreased in liver disease, oral anticoagulant drugs, &#x00AD;amyloidosis, DIC, and vitamin deficiency</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Fibrinogen</p></td>
<td class="td2_line"><p class="tbodyleft">200&#x2013;400 mg/dL</p></td>
<td class="td2_line"><p class="tbodyleft">2&#x2013;4 g/dL</p></td>
<td class="td2_line"><p class="tbodyleft">Increased in pregnancy, infections, inflammation, acute MI, nephritic syndrome, cancers, and stroke</p>
<p class="tbodyleft">Decreased in liver disease, DIC, cancer, primary fibrinolysis, and hereditary and congenital hypofibrinogenemia</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Fibrin degradation products</p></td>
<td class="td1_line"><p class="tbodyleft">&#x003C;10 &#x03BC;g/mL</p></td>
<td class="td1_line"><p class="tbodyleft">&#x003C;10 mg/mL</p></td>
<td class="td1_line"><p class="tbodyleft">Used to establish diagnosis of DIC and other thromboembolic disorders</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Fibrinolysis (whole blood clot lysis time)</p></td>
<td class="td2_line"><p class="tbodyleft">No lysis in 24 h</p></td>
<td class="td2_line"></td>
<td class="td2_line"><p class="tbodyleft">Increased activity associated with hemorrhage and circulatory collapse, surgery, long-term DIC, liver disease, pregnancy complications, and other conditions</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Activated partial &#x00AD;thromboplastin time (aPTT)</p></td>
<td class="td1_line"><p class="tbodyleft">Lower limit of normal: 21&#x2013;35 s</p></td>
<td class="td1_line"></td>
<td class="td1_line"><p class="tbodyleft">Prolonged in deficiency of fibrinogen; factors II, V, VIII, IX, X, XI, and XII; in heparin therapy; DIC; liver disease; and other conditions</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Prothrombin (PT)</p></td>
<td class="td2_line"><p class="tbodyleft">Lower limit of normal: 11 s</p>
<p class="tbodyleft">Lower limit of normal: 13 s</p></td>
<td class="td2_line"></td>
<td class="td2_line"><p class="tbodyleft">Impaired in deficiency of factors II, V, VIII, IX, and X; DIC; liver disease; and other conditions</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">INR</p></td>
<td class="td1_line"><p class="tbodyleft">0.8&#x2013;1.2</p></td>
<td class="td1_line"></td>
<td class="td1_line"><p class="tbodyleft">Prolonged by deficiency of factors I, II, V, VII, and X; fat malabsorption; severe liver disease; warfarin (Coumadin) anticoagulant therapy; and other conditions</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Erythrocyte count</p></td>
<td class="td2_line"><p class="tbodyleft">Males: 4,200,000&#x2013;<br />5,400,000/mm<sup>3</sup></p></td>
<td class="td2_line"><p class="tbodyleft">4.2&#x2013;5.4 &#x00D7; 10<sup>12</sup>/L</p></td>
<td class="td2_line"><p class="tbodyleft">Increased in severe diarrhea and dehydration, polycythemia, acute poisoning, and pulmonary fibrosis</p></td>
</tr>
<tr>
<td class="td2"></td>
<td class="td2"><p class="tbodyleft">Females: 3,600,000&#x2013;5,000,000/mm<sup>3</sup></p></td>
<td class="td2"><p class="tbodyleft">3.6&#x2013;5.0 &#x00D7; 10<sup>12</sup>/L</p></td>
<td class="td2"><p class="tbodyleft">Decreased in all anemias, in leukemia, and after hemorrhage when blood volume has been restored</p></td>
</tr>
<tr>
<td class="td1_line" colspan="4"><p class="tbodyleft"><strong>Erythrocyte Indices</strong></p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">Mean corpuscular volume (MCV)</p></td>
<td class="td1"><p class="tbodyleft">82&#x2013;98 mcm<sup>3</sup></p></td>
<td class="td1"><p class="tbodyleft">82&#x2013;98 fL</p></td>
<td class="td1"><p class="tbodyleft">Increased in macrocytic anemia; decreased in microcytic anemia</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">Mean corpuscular &#x00AD;hemoglobin (MCH)</p></td>
<td class="td1"><p class="tbodyleft">26&#x2013;34 pg/cell</p></td>
<td class="td1"><p class="tbodyleft">0.40 to 0.53 fmol/cell</p></td>
<td class="td1"><p class="tbodyleft">Increased in macrocytic anemia; decreased in microcytic anemia</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">Mean corpuscular hemoglobin concentration (MCHC)</p></td>
<td class="td1"><p class="tbodyleft">32&#x2013;36 g/dL</p></td>
<td class="td1"><p class="tbodyleft">4.9 to 5.5 mmol/L</p></td>
<td class="td1"><p class="tbodyleft">Decreased in severe hypochromic anemia</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">Reticulocytes</p></td>
<td class="td1"><p class="tbodyleft">0.5&#x2013;1.5% of RBCs</p></td>
<td class="td1"><p class="tbodyleft">Number fraction: 0.005&#x2013;0.015</p></td>
<td class="td1"><p class="tbodyleft">Increased with any condition stimulating increase in bone marrow activity (e.g., infection, blood loss [acute and chronically following iron therapy in iron deficiency &#x00AD;anemia], polycythemia vera)</p></td>
</tr>
<tr>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"><p class="tbodyleft">Decreased with any condition depressing bone marrow &#x00AD;activity, acute leukemia, late stage of severe anemias</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">ESR</p></td>
<td class="td1"><p class="tbodyleft">Males under 50 yrs: 0&#x2013;15 mm/h</p><p class="tbodyleft">Males over 50 yrs: 0&#x2013;20 mm/h</p><p class="tbodyleft">Females under 50 yrs: 0&#x2013;20 mm/h</p><p class="tbodyleft">Females over 50 yrs: 0&#x2013;30 mm/h</p></td>
<td class="td1"><p class="tbodyleft">&#x003C;15 mm/h</p><p class="tbodyleft">&#x003C;20 mm/h</p><p class="tbodyleft">&#x003C;25 mm/h</p><p class="tbodyleft">&#x003C;30 mm/h</p></td>
<td class="td1"><p class="tbodyleft">Increased in tissue destruction, whether inflammatory or degenerative; during menstruation and pregnancy; in acute febrile diseases; and other conditions</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">Hematocrit</p></td>
<td class="td1"><p class="tbodyleft">Males: 42&#x2013;52%</p><p class="tbodyleft">Females: 36&#x2013;48%</p></td>
<td class="td1"><p class="tbodyleft">Volume fraction: 0.42&#x2013;0.52</p><p class="tbodyleft">Volume fraction: 0.36&#x2013;0.48</p></td>
<td class="td1"><p class="tbodyleft">Decreased in anemias, including anemia of pregnancy, acute blood loss, and other conditions</p></td>
</tr>
<tr>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"><p class="tbodyleft">Increased in erythrocytosis of any cause, and in dehydration or hemoconcentration associated with shock</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">Hemoglobin</p></td>
<td class="td1"><p class="tbodyleft">Males: 14.0&#x2013;17.4 g/dL</p><p class="tbodyleft">Females: 12.0&#x2013;16 g/dL</p></td>
<td class="td1"><p class="tbodyleft">140&#x2013;174 g/L mmol/L</p><p class="tbodyleft">120&#x2013;160 g/L</p></td>
<td class="td1"><p class="tbodyleft">Decreased in anemias, pregnancy, hemorrhage, with excessive fluid intake, and other conditions</p></td>
</tr>
<tr>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"><p class="tbodyleft">Increased in polycythemia, chronic obstructive pulmonary disease, failure of oxygenation because of congestive heart failure, and normally in people living at high altitudes</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">Leukocyte alkaline phosphatase</p></td>
<td class="td1"><p class="tbodyleft">40&#x2013;100 units</p></td>
<td class="td1"></td>
<td class="td1"><p class="tbodyleft">Increased in polycythemia vera, myelofibrosis, various &#x00AD;cancers, and other conditions</p></td>
</tr>
<tr>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"><p class="tbodyleft">Decreased in chronic myeloid leukemia, paroxysmal &#x00AD;nocturnal hemoglobinuria, idiopathic thrombocytopenic purpura, hereditary hypophosphatasia, progressive &#x00AD;muscular dystrophy, marked eosinophilia, nephritic syndrome, and siderocytic anemia</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">Leukocyte count</p><p class="tbodyleft"> Neutrophils</p></td>
<td class="td1"><p class="tbodyleft">Total: 4500&#x2013;11,000/mm<sup>3</sup></p><p class="tbodyleft">45&#x2013;73%</p></td>
<td class="td1"><p class="tbodyleft">4.5 &#x00D7; 10<sup>9</sup>/L</p><p class="tbodyleft">Number fraction: 0.45&#x2013;0.73</p></td>
<td class="td1"><p class="tbodyleft">Neutrophils increase with acute infections, trauma or &#x00AD;surgery, leukemia, malignant disease, necrosis; decreased with viral infections, bone marrow suppression, primary bone marrow disease</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">&#160;&#160;&#160;Eosinophils</p></td>
<td class="td1"><p class="tbodyleft">0&#x2013;4%</p></td>
<td class="td1"><p class="tbodyleft">Number fraction: 0.00&#x2013;0.04</p></td>
<td class="td1"><p class="tbodyleft">Eosinophils increased in allergy, parasitic disease, collagen disease, subacute infections; decreased with stress, use of some medications (ACTH, epinephrine, thyroxine)</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">&#160;&#160;&#160;Basophils</p></td>
<td class="td1"><p class="tbodyleft">0&#x2013;1%</p></td>
<td class="td1"><p class="tbodyleft">Number fraction: 0.00&#x2013;0.01</p></td>
<td class="td1"><p class="tbodyleft">Basophils increased with acute leukemia and following &#x00AD;surgery or trauma; decreased with allergic reactions, stress, allergy, parasitic disease, use of corticosteroids</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">&#160;&#160;&#160;Lymphocytes</p></td>
<td class="td1"><p class="tbodyleft">20&#x2013;40%</p></td>
<td class="td1"><p class="tbodyleft">Number fraction: 0.2&#x2013;0.4</p></td>
<td class="td1"><p class="tbodyleft">Lymphocytes increased with infectious mononucleosis, viral and some bacterial infections, hepatitis; decreased with aplastic anemia, SLE, immune deficiency including AIDS</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">&#160;&#160;&#160;Monocytes</p></td>
<td class="td1"><p class="tbodyleft">2&#x2013;8%</p></td>
<td class="td1"><p class="tbodyleft">Number fraction: 0.02&#x2013;0.08</p></td>
<td class="td1"><p class="tbodyleft">Monocytes increased with viral infections, parasitic disease, collagen and hemolytic disorders; decreased with use of corticosteroids, RA, HIV infection</p></td>
</tr>
<tr>
<td class="td1"><p class="tbodyleft">Platelet count</p></td>
<td class="td1"><p class="tbodyleft">140,000&#x2013;400,000/mm<sup>3</sup></p></td>
<td class="td1"><p class="tbodyleft">0.14&#x2013;0.4 &#x00D7; 10<sup>12</sup>/L</p></td>
<td class="td1"><p class="tbodyleft">Increased in cancer, myeloproliferative disease, RA, and postoperatively</p></td>
</tr>
<tr>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"></td>
<td class="td1"><p class="tbodyleft">Decreased in thrombocytopenic purpura, acute leukemia, aplastic anemia, and during cancer chemotherapy</p></td>
</tr>
</table>
<p class="tablesource"><em><sup><a id="ft1" href="#fn1">a</a></sup></em>Laboratory values and reference ranges may vary in different laboratories.</p>
<p class="tablesource">ACTH, adrenocorticotropic hormone; AIDS, acquired immune deficiency syndrome; DIC, disseminated intravascular coagulation; ESR, erythrocyte sedimentation rate; HIV, human immune deficiency virus; INR, international normalized ratio; MI, myocardial infarction; RA, rheumatoid arthritis; RBC, red blood cell; SLE, systemic lupus erythematosus.</p>
</div>
<div class="table">
<table class="tbo" id="ttapp2">
<colgroup>
<col style="width:20%"></col>
<col style="width:80%"></col>
</colgroup>
<tr>
<td class="tdnum"><p class="tnum"><strong>TABLE&#x00A0;A-2</strong></p></td>
<td><p class="tcaption">Reference Ranges&#x2014;Serum, Plasma, and Whole Blood Chemistries</p></td>
</tr>
</table>
<p class="timage"><img src="images/app2.jpg" alt=""/></p>
<p class="timage"><img src="images/app2a.jpg" alt=""/></p>
<p class="timage"><img src="images/app2b.jpg" alt=""/></p>
<p class="timage"><img src="images/app2c.jpg" alt=""/></p>
<p class="timage"><img src="images/app2d.jpg" alt=""/></p>
<p class="timage"><img src="images/app2e.jpg" alt=""/></p>
<p class="timage"><img src="images/app2f.jpg" alt=""/></p>
<p class="timage"><img src="images/app2g.jpg" alt=""/></p>
<p class="timage"><img src="images/app2h.jpg" alt=""/></p>
<p class="timage"><img src="images/app2i.jpg" alt=""/></p>
</div>
<div class="table">
<table class="tbo" id="ttapp3">
<colgroup>
<col style="width:20%"></col>
<col style="width:80%"></col>
</colgroup>
<tr>
<td class="tdnum"><p class="tnum"><strong>TABLE&#x00A0;A-3</strong></p></td>
<td><p class="tcaption">Reference Ranges&#x2014;Immunodiagnostic Test</p></td>
</tr>
</table>
<table class="table">
<tr><td class="thead"><p class="T2">Test</p></td>
<td class="thead"><p class="T2">Normal Value</p></td>
<td class="thead"><p class="T2">Clinical Significance</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Acetylcholine receptor binding antibody</p></td>
<td class="td1_line"><p class="tbodyleft">Negative or &#x003C;0.03 nmol/L</p></td>
<td class="td1_line"><p class="tbodyleft">Considered to be diagnostic for myasthenia gravis in patients with symptoms</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Anti&#x2013;ds-DNA antibody</p></td>
<td class="td2_line"><p class="tbodyleft">&#x003C;70 U by enzyme-linked immunosorbent assay (ELISA)</p>
<p class="tbodyleft">&#x003C;1:20 by indirect fluorescence</p></td>
<td class="td2_line"><p class="tbodyleft">Valuable in supporting diagnosis or monitoring disease activity and prognosis of systemic lupus erythematosus (SLE)</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Antiglomerular basement membrane antibody</p></td>
<td class="td1_line"><p class="tbodyleft">Negative or &#x003C;5 UL</p></td>
<td class="td1_line"><p class="tbodyleft">Primarily used in the differential diagnosis of glomerular nephritis induced by antiglomerular basement membrane antibodies from other types of glomerular nephritis</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Anti-insulin antibody</p></td>
<td class="td2_line"><p class="tbodyleft">&#x003C;3% binding of labeled beef and pork insulin by patient&#x2019;s serum; or &#x003C;9 mIU/L</p></td>
<td class="td2_line"><p class="tbodyleft">Helpful in determining the best therapeutic agent in patients with diabetes and the cause of allergic manifestations. Also used to identify insulin resistance</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Antinuclear antibody (ANA)</p></td>
<td class="td1_line"><p class="tbodyleft">Negative, &#x003C;1:40</p></td>
<td class="td1_line"><p class="tbodyleft">Increased in SLE, chronic hepatitis, scleroderma, leukemia, and mononucleosis</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Antiparietal cell antibody</p></td>
<td class="td2_line"><p class="tbodyleft">Negative</p></td>
<td class="td2_line"><p class="tbodyleft">Helpful in diagnosing chronic gastric disease and differentiating autoimmune pernicious anemia from other megaloblastic anemias</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Antiribonucleoprotein antibody</p></td>
<td class="td1_line"><p class="tbodyleft">Negative</p></td>
<td class="td1_line"><p class="tbodyleft">Helpful in differential diagnosis of systemic rheumatic disease</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Antiscleroderma antibody</p></td>
<td class="td2_line"><p class="tbodyleft">Negative</p></td>
<td class="td2_line"><p class="tbodyleft">Highly diagnostic for scleroderma</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Anti-Smith antibody</p></td>
<td class="td1_line"><p class="tbodyleft">Negative</p></td>
<td class="td1_line"><p class="tbodyleft">Highly diagnostic of SLE</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Anti&#x2013;SS-A/anti&#x2013;SS-B antibody</p></td>
<td class="td2_line"><p class="tbodyleft">Negative</p></td>
<td class="td2_line"><p class="tbodyleft">SS-A antibodies are found in Sj&#x00F6;gren syndrome alone or associated with lupus</p>
<p class="tbodyleft">SS-B antibodies are associated with primary Sj&#x00F6;gren syndrome</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Antithyroglobulin and antimicrosomal antibodies</p></td>
<td class="td1_line"><p class="tbodyleft">&#x003C;1:100 titer by gelatin or hemagglutination</p></td>
<td class="td1_line"><p class="tbodyleft">Presence and concentration is important in evaluation and treatment of various thyroid disorders, such as Hashimoto thyroiditis and Graves disease. May indicate previous autoimmune disorders</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">CA 15&#x2013;3 tumor marker</p></td>
<td class="td2_line"><p class="tbodyleft">&#x003C;30 IU/mL</p></td>
<td class="td2_line"><p class="tbodyleft">Increased in metastatic breast cancer</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">CA 19&#x2013;9 tumor marker</p></td>
<td class="td1_line"><p class="tbodyleft">&#x003C;37 IU/mL</p></td>
<td class="td1_line"><p class="tbodyleft">Increased in pancreatic, hepatobiliary, gastric, and colorectal cancer; gallstones</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">CA 125</p></td>
<td class="td2_line"><p class="tbodyleft">0&#x2013;35 IU/mL</p></td>
<td class="td2_line"><p class="tbodyleft">Increased in colon, upper gastrointestinal (GI), ovarian, and other gynecologic cancers: pregnancy, peritonitis</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Carcinoembryonic antigen (CEA)&#x2014;RLK</p></td>
<td class="td1_line"><p class="tbodyleft">0&#x2013;2.5 mcg/L (nonsmoker)</p>
<p class="tbodyleft">0&#x2013;5 mcg/L (smoker)</p></td>
<td class="td1_line"><p class="tbodyleft">The repeatedly high incidence of this antigen in cancers of the colon, rectum, pancreas, and stomach suggests that CEA levels may be useful in the therapeutic monitoring of these conditions, but it is not a screening test</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Cold agglutinins</p></td>
<td class="td2_line"><p class="tbodyleft">Negative or &#x003C;1:64</p></td>
<td class="td2_line"><p class="tbodyleft">Increased in mycoplasma pneumonia, viral illness, mononucleosis, multiple myeloma, and scleroderma</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">C-reactive protein</p></td>
<td class="td1_line"><p class="tbodyleft">&#x003C;1 mg/dL (&#x003C;10 mg/L)</p></td>
<td class="td1_line"><p class="tbodyleft">Increase indicates active inflammation</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">High sensitivity assay for C-reactive protein (hs-CRP)</p></td>
<td class="td2_line"><p class="tbodyleft">0.2&#x2013;8.0 mg/L</p></td>
<td class="td2_line"><p class="tbodyleft">Cardiovascular disease risk</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Cytomegalovirus antibodies (CMV IgG)</p></td>
<td class="td1_line"><p class="tbodyleft">Negative: &#x003C;0.9 units/mL</p></td>
<td class="td1_line"><p class="tbodyleft">Positive &#x003E;1:0 unit/mL if exposed to CMV at any time. Acute and convalescent specimens can help identify acute infection</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Cytomegalovirus antibodies (CMV IgM)</p></td>
<td class="td2_line"><p class="tbodyleft">Negative: &#x003C;0:79</p></td>
<td class="td2_line"><p class="tbodyleft">Positive &#x003E;1:20 usually indicates acute infection</p></td>
</tr>
<tr>
<td class="td2"></td>
<td class="td2"><p class="tbodyleft">Equivocal: 0:80&#x2013;1.20</p></td>
<td class="td2"><p class="tbodyleft">Repeat specimen in 1&#x2013;2 wks for equivocal result</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Epstein&#x2013;Barr virus (EBV) serology (viral capsid antigen IgG and IgM, early antigen IgG, and nuclear antigen IgG)</p></td>
<td class="td1_line"><p class="tbodyleft">Negative</p></td>
<td class="td1_line"><p class="tbodyleft">Differentiation of acute from chronic or old infection</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Hepatitis A virus antibodies, IgM (HAV-Ab/IgM)</p></td>
<td class="td2_line"><p class="tbodyleft">Negative</p></td>
<td class="td2_line"><p class="tbodyleft">Positive in acute-stage hepatitis A; develops early in disease</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Hepatitis A virus antibodies, IgG (HAV-Ab/IgG)</p></td>
<td class="td1_line"><p class="tbodyleft">Negative</p></td>
<td class="td1_line"><p class="tbodyleft">Positive if previous exposure and immunity to hepatitis A</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Hepatitis B surface antigen (HBsAg)</p></td>
<td class="td2_line"><p class="tbodyleft">Negative</p></td>
<td class="td2_line"><p class="tbodyleft">Positive in acute-stage hepatitis B</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Hepatitis B surface antibody (HBsAb)</p></td>
<td class="td1_line"><p class="tbodyleft">Negative</p></td>
<td class="td1_line"><p class="tbodyleft">Positive if previous exposure and immunity to hepatitis B</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Hepatitis C virus antibodies</p></td>
<td class="td2_line"><p class="tbodyleft">Negative</p></td>
<td class="td2_line"><p class="tbodyleft">Positive in exposure to hepatitis C virus; may indicate acute, chronic, or cleared infection</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Hepatitis C virus RNA</p></td>
<td class="td1_line"><p class="tbodyleft">Negative</p></td>
<td class="td1_line"><p class="tbodyleft">Positive in hepatitis C infection, can be quantitative</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Homocysteine</p></td>
<td class="td2_line"><p class="tbodyleft">0.54&#x2013;2.30 mg/L (4&#x2013;17 mcmol/L)</p></td>
<td class="td2_line"><p class="tbodyleft">Cardiovascular disease risk</p>
<p class="tbodyleft">Folic acid deficiency</p>
<p class="tbodyleft">Vitamin B<sub>12</sub> deficiency</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Infectious mononucleosis tests (&#x00AD;monospot, monotest, heterophile antigen test, EBV, antiviral capsid &#x00AD;antigen IgM and IgG)</p></td>
<td class="td1_line"><p class="tbodyleft">Negative</p></td>
<td class="td1_line"><p class="tbodyleft">Positive monospot and monotest are presumptive, positive EBV IgM and IgG indicate acute and recent or past infection, respectively</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Lyme disease titer</p></td>
<td class="td2_line"><p class="tbodyleft">Negative, &#x003C;1:256 by indirect fluorescent antibody method; nonreactive by ELISA</p></td>
<td class="td2_line"><p class="tbodyleft">Positive results help diagnose Lyme disease. False positive may occur with high rheumatoid factor titers or syphilis</p>
<p class="tbodyleft">Positive ELISA confirmed by Western blot test</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">Pyroglobulin test</p></td>
<td class="td1_line"><p class="tbodyleft">Negative</p></td>
<td class="td1_line"><p class="tbodyleft">These abnormal proteins may be associated with myeloma, lymphoma, polycythemia vera, and SLE</p></td>
</tr>
<tr>
<td class="td2_line"><p class="tbodyleft">Rheumatoid factor</p></td>
<td class="td2_line"><p class="tbodyleft">Negative</p></td>
<td class="td2_line"><p class="tbodyleft">Elevated in rheumatoid arthritis, lupus endocarditis, tuberculosis, syphilis, sarcoidosis, and cancer</p></td>
</tr>
<tr>
<td class="td1_line"><p class="tbodyleft">T- and B-cell lymphocyte surface markers</p>
<p class="tbodyleft">T-helper/T-suppressor ratio</p></td>
<td class="td1_line"><p class="tbodyleft">T- and B-cell lymphocyte surface markers:</p>
<p class="tbodyleft">Percent T cells (CD2) 60&#x2013;88%</p>
<p class="tbodyleft">Percent helper cells (CD4) 34&#x2013;67%</p>
<p class="tbodyleft">Percent suppressor cells (CD8) 10&#x2013;42%</p>
<p class="tbodyleft">Percent B cells (CD19) 3&#x2013;21%</p></td>
<td class="td1_line"><p class="tbodyleft">Used to evaluate immune system by identifying the specific cells involved in the immune response. Valuable in diagnosis of lymphocytic leukemia, lymphoma, and immunodeficiency diseases including AIDS; and in the assessment of patient response to chemotherapy and radiation</p></td>
</tr>
<tr>
<td class="td1"></td>
<td class="td1"><p class="tbodyleft">Absolute counts:</p>
<p class="tbodyleft">Lymphocytes 0.66&#x2013;4.60 thou/mL</p>
<p class="tbodyleft">T cells 644&#x2013;2201 cells/mL</p>
<p class="tbodyleft">Helper cells 493&#x2013;1191 cells/mL</p>
<p class="tbodyleft">Suppressor T cells 182&#x2013;785 cells/mL</p>
<p class="tbodyleft">B cells 92&#x2013;392 cells/mL</p></td>
<td class="td1"></td>
</tr>
<tr>
<td class="td1"></td>
<td class="td1"><p class="tbodyleft">Lymphocyte ratio:</p></td>
<td class="td1"></td>
</tr>
<tr>
<td class="td1"></td>
<td class="td1"><p class="tbodyleft">T<sub>H</sub>/T<sub>S</sub> ratio &#x003E;1</p></td>
<td class="td1"></td>
</tr>
</table>
</div>
<div class="table">
<table class="tbo" id="ttapp4">
<colgroup>
<col style="width:20%"></col>
<col style="width:80%"></col>
</colgroup>
<tr>
<td class="tdnum"><p class="tnum"><strong>TABLE&#x00A0;A-4</strong></p></td>
<td><p class="tcaption">Reference Ranges&#x2014;Urine Chemistry</p></td>
</tr>
</table>
<p class="timage"><img src="images/appt4.jpg" alt=""/></p>
<p class="timage"><img src="images/appt4a.jpg" alt=""/></p>
<p class="timage"><img src="images/appt4b.jpg" alt=""/></p>
<p class="timage"><img src="images/appt4c.jpg" alt=""/></p>
</div>
<div class="table">
<table class="tbo" id="ttapp5">
<colgroup>
<col style="width:20%"></col>
<col style="width:80%"></col>
</colgroup>
<tr>
<td class="tdnum"><p class="tnum"><strong>TABLE&#x00A0;A-5</strong></p></td>
<td><p class="tcaption">Selected Reference Ranges&#x2014;Cerebrospinal Fluid</p></td>
</tr>
</table>
<p class="timage"><img src="images/appt5.jpg" alt=""/></p>
</div>
<p class="BIBLIOGRAPHYpTitle"><strong>REFERENCES</strong></p>
<p class="bib">Fischbach, F. T., &#x0026; Fischbach, M. A. (2018). <em>A manual of laboratory and diagnostic tests</em> (10th ed.). Philadelphia, PA: Wolters Kluwer.</p>
</div>
</section>
</body>
</html>